Apogee Therapeutics (APGE) Interest & Investment Income (2023 - 2026)
Apogee Therapeutics (APGE) posted quarterly Interest & Investment Income of $8.7 million for Q1 2026, up 11.48% year-over-year from $7.8 million in Q1 2025, and little changed quarter-over-quarter from $8.7 million in Q4 2025.
Apogee Therapeutics (APGE) Interest & Investment Income (2023 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Interest & Investment Income for 4 consecutive years, with $8.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 11.48% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $23.4 million (down 10.27% YoY), while the FY2025 annual figure was $30.0 million, down 13.56% from the prior year.
- Interest & Investment Income was little changed at $8.7 million in Q1 2026 per APGE's latest filing, from $8.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $9.7 million in Q3 2024 and bottomed at -$506000.0 in Q1 2024.
- Historically, Interest & Investment Income has averaged $4.8 million across 4 years, with a median of $5.9 million in 2023.
- Annual changes were most pronounced in 2024 — Interest & Investment Income slumped 480.45% — and 2025, when it soared 1649.41%.
- Apogee Therapeutics' Interest & Investment Income stood at $5.4 million in 2023, then soared by 60.17% to $8.7 million in 2024, then grew by 0.58% to $8.7 million in 2025, then increased by 0.1% to $8.7 million in 2026.
- Business Quant data shows APGE's Interest & Investment Income at $8.7 million in Q1 2026, $8.7 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | 11.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.81 Mn |
| Mar 31, 2026 | 8.74 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Sep 30, 2025 | 6.32 Mn |
| Jun 30, 2025 | -389,000.00 |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 9.67 Mn |
| Jun 30, 2024 | -112,000.00 |
| Mar 31, 2024 | -506,000.00 |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 133,000.00 |